Equillium Statistics
Total Valuation
Equillium has a market cap or net worth of $117.60 million. The enterprise value is $88.68 million.
Important Dates
The next estimated earnings date is Monday, May 25, 2026, after market close.
| Earnings Date | May 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Equillium has 63.23 million shares outstanding. The number of shares has increased by 62.07% in one year.
| Current Share Class | 63.23M |
| Shares Outstanding | 63.23M |
| Shares Change (YoY) | +62.07% |
| Shares Change (QoQ) | +40.66% |
| Owned by Insiders (%) | 10.85% |
| Owned by Institutions (%) | 32.30% |
| Float | 31.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.13 |
| P/TBV Ratio | 4.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.58, with a Debt / Equity ratio of 0.03.
| Current Ratio | 10.58 |
| Quick Ratio | 10.36 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -93.99% and return on invested capital (ROIC) is -60.59%.
| Return on Equity (ROE) | -93.99% |
| Return on Assets (ROA) | -51.39% |
| Return on Invested Capital (ROIC) | -60.59% |
| Return on Capital Employed (ROCE) | -81.63% |
| Weighted Average Cost of Capital (WACC) | 13.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$639,943 |
| Employee Count | 35 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +329.97% in the last 52 weeks. The beta is 1.74, so Equillium's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | +329.97% |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | 1.29 |
| Relative Strength Index (RSI) | 49.91 |
| Average Volume (20 Days) | 621,029 |
Short Selling Information
The latest short interest is 2.00 million, so 3.16% of the outstanding shares have been sold short.
| Short Interest | 2.00M |
| Short Previous Month | 2.08M |
| Short % of Shares Out | 3.16% |
| Short % of Float | 6.34% |
| Short Ratio (days to cover) | 3.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.63M |
| Pretax Income | -22.40M |
| Net Income | -22.40M |
| EBITDA | -23.52M |
| EBIT | -23.63M |
| Earnings Per Share (EPS) | -$0.39 |
Full Income Statement Balance Sheet
The company has $30.28 million in cash and $719,000 in debt, with a net cash position of $29.56 million or $0.47 per share.
| Cash & Cash Equivalents | 30.28M |
| Total Debt | 719,000 |
| Net Cash | 29.56M |
| Net Cash Per Share | $0.47 |
| Equity (Book Value) | 28.60M |
| Book Value Per Share | 0.47 |
| Working Capital | 28.10M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$22.75 million and capital expenditures -$48,000, giving a free cash flow of -$22.79 million.
| Operating Cash Flow | -22.75M |
| Capital Expenditures | -48,000 |
| Depreciation & Amortization | 116,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -22.79M |
| FCF Per Share | -$0.36 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Equillium does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.07% |
| Shareholder Yield | -62.07% |
| Earnings Yield | -18.94% |
| FCF Yield | -19.28% |
Analyst Forecast
The average price target for Equillium is $12.00, which is 545.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 545.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -0.50% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |